Using peripheral smear review, age and absolute lymphocyte count as predictors of abnormal peripheral blood lymphocytoses diagnosed by flow cytometry

被引:18
作者
Andrews, Jared M. [1 ]
Cruser, Dan L. [1 ]
Myers, Jerome B. [1 ]
Fernelius, Colby A. [1 ]
Holm, Mitchel T. [1 ]
Waldner, Dale L. [1 ]
机构
[1] Madigan Army Med Ctr, Dept Pathol, Tacoma, WA 98431 USA
关键词
lymphoid leukemia; lymphocytes; prognostication;
D O I
10.1080/10428190802251787
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Absolute lymphocytosis in the elderly raises the possibility of malignancy and generally warrants further investigation. To better correlate clinical variables with the frequency of neoplastic lymphoid processes in this population, we retrospectively reviewed archived flow cytometric analyses from peripheral blood specimens on patients of 50 years of age and older that had been deemed suspicious for a lymphoproliferative process after peripheral smear review. Age, absolute lymphocyte count (ALC), white blood cell count and relative lymphocyte count were correlated with the results of flow cytometry. Of 71 total cases, 42 (59%) had an abnormal immunophenotype. Independent variables that showed significant differences between normal and abnormal immunophenotype were mean age (p=0.001) and ALC (p=0.0032). We combined age and absolute lymphocyte count variables to look for the best possible cutoff values to predict the likelihood of an abnormal immunophenotype. ALC cutoff values of >= 4 x 10(9) cells/L for patients over 67 years of age, and > 6.7 x 10(9) cells/L for patients between 50 and 67 years of age, had a high sensitivity for detecting an abnormal immunophenotype.
引用
收藏
页码:1731 / 1737
页数:7
相关论文
共 20 条
[1]   Emerging therapy for chronic lymphocytic leukaemia [J].
Auer, Rebecca L. ;
Gribben, John ;
Cotter, Finbarr E. .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (05) :635-644
[2]   A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia [J].
Calin, GA ;
Ferracin, M ;
Cimmino, A ;
Di Leva, G ;
Shimizu, M ;
Wojcik, SE ;
Iorio, MV ;
Visone, R ;
Sever, NI ;
Fabbri, M ;
Iuliano, R ;
Palumbo, T ;
Pichiorri, F ;
Roldo, C ;
Garzon, R ;
Sevignani, C ;
Rassenti, L ;
Alder, H ;
Volinia, S ;
Liu, CG ;
Kipps, TJ ;
Negrini, M ;
Croce, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1793-1801
[3]  
Cao Thai M, 2003, Curr Hematol Rep, V2, P65
[4]   National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment [J].
Cheson, BD ;
Bennett, JM ;
Grever, M ;
Kay, N ;
Keating, MJ ;
OBrien, S ;
Rai, KR .
BLOOD, 1996, 87 (12) :4990-4997
[5]   Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia [J].
D'Arena, Giovanni ;
Tarnani, Michela ;
Rumi, Carlo ;
Vaisitti, Tiziana ;
Aydin, Sernra ;
De Filippi, Rosaria ;
Perrone, Francesco ;
Pinto, Antonio ;
Chiusolo, Patrizia ;
Deaglio, Silvia ;
Malavasi, Fabio ;
Laurentl, Luca .
AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (09) :787-791
[6]   Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly [J].
Ghia, P ;
Prato, G ;
Scielzo, C ;
Stella, S ;
Geuna, M ;
Guida, G ;
Caligaris-Cappio, F .
BLOOD, 2004, 103 (06) :2337-2342
[7]   CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease [J].
Hamblin, TJ ;
Orchard, JA ;
Ibbotson, RE ;
Davis, Z ;
Thomas, PW ;
Stevenson, FK ;
Oscier, DG .
BLOOD, 2002, 99 (03) :1023-1029
[8]  
*INT SOC LAB HEM, CONS GUID RUL
[9]  
JACK A, 1997, P USPHS WORKSH LAB A, P93
[10]  
Juneja S, 1995, CLIN LAB HAEMATOL, V17, P335